These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21225461)

  • 21. More than a message: framing public health advocacy to change corporate practices.
    Dorfman L; Wallack L; Woodruff K
    Health Educ Behav; 2005 Jun; 32(3):320-36; discussion 355-62. PubMed ID: 15851542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US.
    Wakefield T; Glantz SA; Apollonio DE
    JAMA Netw Open; 2022 Aug; 5(8):e2228088. PubMed ID: 35997980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Official Turnover and Corporate ESG Practices: Evidence from China.
    Yang Y; Xu G; Li R
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):51422-51439. PubMed ID: 36809631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategic corporate entrepreneurship practices in financial services firms: the role of organizational factors.
    Casales Morici B
    SN Bus Econ; 2022; 2(9):130. PubMed ID: 35992740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Private and personal": Corporate political activity, informal governance, and the undermining of marketing regulation in Brazil.
    Carvalho CMP; Johns P; Albiero M; Martins APB; Mais LA; Ralston R; Collin J
    Glob Public Health; 2022; 17(9):1902-1912. PubMed ID: 34648410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards an understanding of corporate image in the hospitality industry East Java, Indonesia.
    Triatmanto B; Respati H; Wahyuni N
    Heliyon; 2021 Mar; 7(3):e06404. PubMed ID: 33748476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to expand corporate autonomy by the tobacco, alcohol and sugar-sweetened beverage industry: a scoping review of reviews.
    Hoe C; Weiger C; Minosa MKR; Alonso F; Koon AD; Cohen JE
    Global Health; 2022 Feb; 18(1):17. PubMed ID: 35164801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Alcohol Industry Submissions against Marketing Regulation.
    Martino FP; Miller PG; Coomber K; Hancock L; Kypri K
    PLoS One; 2017; 12(1):e0170366. PubMed ID: 28118411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship marketing of health care plans: retaining corporate customers in a competitive environment.
    Choong P
    Health Mark Q; 2000; 17(4):37-50. PubMed ID: 11183659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The manufacture of lifestyle: the role of corporations in unhealthy living.
    Freudenberg N
    J Public Health Policy; 2012 May; 33(2):244-56. PubMed ID: 22258282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the health impact of transnational corporations: a case study on McDonald's Australia.
    Anaf J; Baum FE; Fisher M; Harris E; Friel S
    Global Health; 2017 Feb; 13(1):7. PubMed ID: 28166801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries.
    Allen LN; Wigley S; Holmer H
    Soc Sci Med; 2022 Mar; 297():114825. PubMed ID: 35228150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.
    Lacy-Nichols J; Williams O
    Int J Health Policy Manag; 2021 Dec; 10(12):845-856. PubMed ID: 34634883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International codes and agreements to restrict the promotion of harmful products can hold lessons for the control of alcohol marketing.
    Landon J; Lobstein T; Godfrey F; Johns P; Brookes C; Jernigan D
    Addiction; 2017 Jan; 112 Suppl 1():102-108. PubMed ID: 27753203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Environmental Uncertainty on Corporate Innovation: Empirical Evidence from an Emerging Economy.
    Chen J; Shu W; Wang X; Sial MS; Sehleanu M; Badulescu D
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental Pollution Liability Insurance and Corporate Performance: Evidence from China in the Perspective of Green Development.
    Yang R; Zhang R
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkages between clinical practices and community organizations for prevention: a literature review and environmental scan.
    Porterfield DS; Hinnant LW; Kane H; Horne J; McAleer K; Roussel A
    Am J Prev Med; 2012 Jun; 42(6 Suppl 2):S163-71. PubMed ID: 22704433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.